Development and validation of an UV spectrophotometric method for the determination of aliskiren in tablets
AUTOR(ES)
Wrasse-Sangoi, Micheli, Secretti, Leonardo Trevisan, Diefenbach, Isabel Fração, Rolim, Clarice Madalena Bueno, Sangoi, Maximiliano da Silva
FONTE
Química Nova
DATA DE PUBLICAÇÃO
2010
RESUMO
For determination of aliskiren in commercial samples, an analytical UV spectrophotometric method was developed and validate according to ICH guideline. The method was linear in the range between 40 and 100 μg mL-1 (r² = 0.9997, n = 7) and exhibited suitable specificity, accuracy, precision, and robustness. It is simple, it has low cost, and it has low use polluting reagents. Therefore, the proposed method was successfully applied for the assay and dissolution studies of aliskiren in tablet dosage forms, and the results were compared to a validated RP-LC method, showing non-significant difference (P > 0.05).
Documentos Relacionados
- Development and validation of an UV-derivative spectrophotometric method for determination of glimepiride in tablets
- UV derivative spectrophotometric method for determination of estradiol valerate in tablets
- Development and validation of UV spectrophotometric method for determination of levofloxacin in pharmaceutical dosage forms
- Validation of a simple and rapid UV spectrophotometric method for dexamethasone assay in tablets
- Development and validation of UV spectrophotometric method for orbifloxacin assay and dissolution studies